hypoglycemia from semaglutide following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data hypoglycemia on semaglutide Cardiovascular Outcomes,

Ophthalmic changes in a spaceflight analog are associated with brain functional reorganization

Physicians should ensure claims note whether the medication was used to treat or alleviate symptoms of deficiency, especially in patients with low serum vitamin B12 or conditions linked to vegan diets or malabsorption syndromes

Botox can help reduce their appearance

Despite the differences across the trials in terms of characteristics of the population, duration and main objective of the study, the data suggest a rather surprising homogeneity in terms of relative risk reduction ( 34% and 12% with SGLT-2i and GLP-1Ra, respectively